ES2794082T3 - Uso de dímeros de IL-22 en la fabricación de medicamentos para tratar la pancreatitis - Google Patents

Uso de dímeros de IL-22 en la fabricación de medicamentos para tratar la pancreatitis Download PDF

Info

Publication number
ES2794082T3
ES2794082T3 ES14860161T ES14860161T ES2794082T3 ES 2794082 T3 ES2794082 T3 ES 2794082T3 ES 14860161 T ES14860161 T ES 14860161T ES 14860161 T ES14860161 T ES 14860161T ES 2794082 T3 ES2794082 T3 ES 2794082T3
Authority
ES
Spain
Prior art keywords
dimer
pancreatitis
seq
individual
use according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES14860161T
Other languages
English (en)
Spanish (es)
Inventor
Xiaoqiang Yan
Cheng Huang
Dongdong Wu
Kaiyang Tang
Yuliang Huang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Generon Shanghai Corp Ltd
Original Assignee
Generon Shanghai Corp Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Generon Shanghai Corp Ltd filed Critical Generon Shanghai Corp Ltd
Application granted granted Critical
Publication of ES2794082T3 publication Critical patent/ES2794082T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Obesity (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
ES14860161T 2013-11-07 2014-11-06 Uso de dímeros de IL-22 en la fabricación de medicamentos para tratar la pancreatitis Active ES2794082T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201310549648.XA CN104623639A (zh) 2013-11-07 2013-11-07 白介素22二聚体在制备治疗胰腺炎药物中的应用
PCT/CN2014/090519 WO2015067198A1 (en) 2013-11-07 2014-11-06 Use of il-22 dimers in manufacture of medicaments for treating pancreatitis

Publications (1)

Publication Number Publication Date
ES2794082T3 true ES2794082T3 (es) 2020-11-17

Family

ID=53040916

Family Applications (1)

Application Number Title Priority Date Filing Date
ES14860161T Active ES2794082T3 (es) 2013-11-07 2014-11-06 Uso de dímeros de IL-22 en la fabricación de medicamentos para tratar la pancreatitis

Country Status (8)

Country Link
US (1) US20160271221A1 (https=)
EP (1) EP3065765B1 (https=)
JP (2) JP6825181B2 (https=)
CN (2) CN104623639A (https=)
AU (1) AU2014346051B2 (https=)
CA (1) CA2929637C (https=)
ES (1) ES2794082T3 (https=)
WO (1) WO2015067198A1 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101361968B (zh) 2007-08-06 2011-08-03 健能隆医药技术（上海）有限公司 白介素-22在治疗脂肪肝中的应用
CN104623637A (zh) 2013-11-07 2015-05-20 健能隆医药技术（上海）有限公司 Il-22二聚体在制备静脉注射药物中的应用
CN106146668A (zh) * 2015-04-01 2016-11-23 中国人民解放军第二军医大学 长效白细胞介素22的制备方法及其用途
EP3303367B1 (en) * 2015-06-08 2025-06-18 New York University Stabilized minimal coiled-coil mimetics
CR20180087A (es) * 2015-07-16 2018-05-14 Philogen Spa Inmunoconjugados de il22
US11510966B2 (en) 2016-04-15 2022-11-29 Evive Biotechnology (Shanghai) Ltd Use of IL-22 in treating necrotizing enterocolitis
MX2021002761A (es) 2018-09-10 2021-05-31 Cold Spring Harbor Laboratory Metodos para tratar la pancreatitis.
CN110302363B (zh) * 2019-07-04 2020-10-09 北京大学第三医院（北京大学第三临床医学院） Il-22作为制备治疗pcos药物的应用及药物制剂
EP4106794A4 (en) * 2020-02-19 2024-03-20 Evive Biotechnology (Shanghai) Ltd METHOD FOR TREATING TRANSPLANT AND HOST DISEASE

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2150803C (en) 1992-12-02 2006-01-31 Henry Auer Controlled release growth hormone containing microspheres
PT779806E (pt) 1994-09-09 2001-02-28 Takeda Chemical Industries Ltd Preparacao de libertacao sustentada contendo um sal metalico de um peptido
PT831787E (pt) 1995-06-07 2002-02-28 Alkermes Inc Composicao para libertacao sustentada da hormona de crescimento humano
ZA965368B (en) 1995-07-14 1997-01-14 Novo Nordisk As A pharmaceutical formulation
US6274710B1 (en) 1998-10-26 2001-08-14 Ludwig Institute For Cancer Research Antibodies which specifically bind T Cell inducible factors (TIFs)
US7597876B2 (en) * 2007-01-11 2009-10-06 Immunomedics, Inc. Methods and compositions for improved F-18 labeling of proteins, peptides and other molecules
CN100515491C (zh) * 2005-01-04 2009-07-22 健能隆医药技术（上海）有限公司 白介素-22的医药用途
CN102380091A (zh) 2010-08-31 2012-03-21 健能隆医药技术（上海）有限公司 白介素-22在治疗病毒性肝炎中的应用
US8690554B2 (en) * 2011-07-15 2014-04-08 Xylem Ip Holdings Llc Diaphragm pump using duckbill and other types of valves
WO2014145016A2 (en) * 2013-03-15 2014-09-18 Genentech, Inc. Il-22 polypeptides and il-22 fc fusion proteins and methods of use

Also Published As

Publication number Publication date
AU2014346051A1 (en) 2016-05-26
EP3065765A4 (en) 2017-08-02
CN105705160B (zh) 2020-02-07
JP2019206548A (ja) 2019-12-05
JP2016536357A (ja) 2016-11-24
JP6825181B2 (ja) 2021-02-03
HK1223556A1 (zh) 2017-08-04
WO2015067198A1 (en) 2015-05-14
EP3065765B1 (en) 2020-04-08
US20160271221A1 (en) 2016-09-22
EP3065765A1 (en) 2016-09-14
CN105705160A (zh) 2016-06-22
CN104623639A (zh) 2015-05-20
CA2929637C (en) 2025-02-11
CA2929637A1 (en) 2015-05-14
AU2014346051B2 (en) 2020-02-27

Similar Documents

Publication Publication Date Title
ES2794082T3 (es) Uso de dímeros de IL-22 en la fabricación de medicamentos para tratar la pancreatitis
ES3026668T3 (en) Use of il-22 dimers in manufacture of a medicament for intravenous administration
AU2020401160B2 (en) Pharmaceutical TACI-Fc fusion protein formulation
ES2819866T3 (es) Polipéptido ANGPTL8 y su uso para el tratamiento de condiciones asociadas con triglicéridos elevados
KR20200085763A (ko) 수술전, 수술동안 또는 수술후 투여용 glp-2 유사체 및 펩티바디
ES3031633T3 (en) Annexin a1 n-terminal peptide formulations and methods
ES2930351T3 (es) Un dímero de IL-22 para su uso en el tratamiento de enterocolitis necrosante
JP2017114867A (ja) ストロマ細胞由来因子−１のプロテアーゼ耐性変異体を用いた、組織損傷を修復するための方法
EP3856767A1 (en) Formulations of glucagon-like-peptide-2 (glp-2) analogues
JP7824885B2 (ja) 表皮水疱症の治療で使用するためのホーミングペプチド誘導デコリン複合体
RU2833459C2 (ru) Составы аналогов глюкагоноподобного пептида-2 (glp-2)
RU2820132C2 (ru) Способ улучшения симптомов со стороны нижних мочевыводящих путей
RU2839726C2 (ru) Способ лечения симптомов со стороны нижних мочевыводящих путей с использованием фексапотида трифлутата
CN121175330A (zh) 溶瘤肽
HK1223556B (zh) Il-22二聚体在制备用於治疗胰腺炎的药物中的用途
HK40002973B (en) An il-22 dimer for use in treating necrotizing enterocolitis
HK40002973A (en) An il-22 dimer for use in treating necrotizing enterocolitis